<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">
Request a proposal

Infographic: Selected deals for SARS-CoV-2 vaccines in late stage development

Did you know Canada has secured deals with all six of the leading vaccine candidates in development, as well as one domestic manufacturer?

With these agreements in place, Canada has purchased the highest number of vaccines (per capita) for the prevention of SARS-CoV-2 infection. If all of the vaccines are successful, Canada will have secured enough doses to vaccinate the entire population at 100% coverage rate, five times over.

Selected deals for SARS-CoV-2 vaccines in late stage development
Selected deals for SARS-CoV-2 vaccines in late stage development

Did you know Canada has secured deals with all six of the leading vaccine candidates in development, as well as one domestic manufacturer?

With these agreements in place, Canada has purchased the highest number of vaccines (per capita) for the prevention of SARS-CoV-2 infection. If all of the vaccines are successful, Canada will have secured enough doses to vaccinate the entire population at 100% coverage rate, five times over.

Form Header

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat.

In our latest infographic, we present a selection of some of the confirmed procurement deals from higher-income countries.

Download the infographic

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here